$1.07
0.032.88%
In chiusura: -
$1.09
0.021.87%
After hour: Nov 7, 6:38 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Fate Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Fate Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Fate Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Fate Therapeutics Inc
Numero di azioni emesse
115.330M
Azioni possedute dagli insider
2.503M
Percentuale posseduta dagli Insider
2.17%
Azioni possedute dagli investitori istituzionali
34.323M
Percentuale posseduta dagli investitori istituzionali
29.8%
Aug 05, 2025 | SEE REMARKS | -9.04K | $1.06 | -$9.57K | SELL | -2.22% | 397.67K | Aug 04 | ||
Aug 05, 2025 | PRESIDENT AND CEO | -14.47K | $1.06 | -$15.40K | SELL | -4.14% | 334.90K | Aug 04 | ||
Jan 13, 2025 | SEE REMARKS | -5.98K | $1.55 | -$9.27K | SELL | -2.17% | 270.20K | Jan 10 | ||
Jan 13, 2025 | SEE REMARKS | -5.65K | $1.55 | -$8.76K | SELL | -1.65% | 336.71K | Jan 10 | ||
Jan 13, 2025 | PRESIDENT AND CEO | -8.71K | $1.54 | -$13.41K | SELL | -2.43% | 349.36K | Jan 10 | ||
Dec 26, 2024 | DIRECTOR | 56.33K | $1.68 | $94.64K | BUY | 0.44% | 12.88M | Dec 20 | ||
Aug 07, 2024 | — | -633.00 | $4.23 | -$2.68K | SELL | -6.80% | 8.67K | Aug 06 | ||
Mar 05, 2024 | CHIEF FINANCIAL OFFICER | -2.45K | $7.77 | -$19.01K | SELL | -2.35% | 101.48K | Mar 04 | ||
Jan 30, 2024 | CHIEF FINANCIAL OFFICER | -1.85K | $5.00 | -$9.24K | SELL | -1.75% | 103.93K | Jan 29 | ||
Jan 10, 2024 | GENERAL COUNSEL AND SECRETARY | -10.87K | $4.37 | -$47.52K | SELL | -7.10% | 142.36K | Jan 09 | ||
Jan 10, 2024 | CHIEF R&D OFFICER | -11.27K | $4.38 | -$49.37K | SELL | -6.66% | 158.07K | Jan 09 | ||
Jan 10, 2024 | PRESIDENT AND CEO | -14.39K | $4.37 | -$62.89K | SELL | -3.73% | 371.25K | Jan 09 | ||
Jan 10, 2024 | CHIEF FINANCIAL OFFICER | -7.03K | $4.37 | -$30.71K | SELL | -6.23% | 105.78K | Jan 09 | ||
Jan 03, 2024 | CHIEF FINANCIAL OFFICER | -5.18K | $3.66 | -$18.97K | SELL | -4.39% | 112.80K | Jan 02 | ||
Dec 28, 2023 | DIRECTOR | 44.63K | $3.72 | $166.02K | BUY | 0.34% | 13.18M | Dec 26 | ||
Dec 19, 2023 | CHIEF FINANCIAL OFFICER | -1.58K | $3.50 | -$5.55K | SELL | -1.33% | 117.98K | Dec 18 | ||
Nov 13, 2023 | GENERAL COUNSEL AND SECRETARY | -24.36K | $2.40 | -$58.47K | SELL | -13.72% | 153.24K | Nov 09 | ||
Aug 21, 2023 | CHIEF FINANCIAL OFFICER | -4.72K | $2.80 | -$13.21K | SELL | -3.80% | 119.57K | Aug 18 | ||
Aug 07, 2023 | DIRECTOR | -632.00 | $3.71 | -$2.34K | SELL | -6.36% | 9.30K | Aug 04 | ||
Jul 06, 2023 | CHIEF COMMERCIAL OFFICER | -3.85K | $4.87 | -$18.77K | SELL | -8.56% | 41.15K | Jul 05 | ||
Jul 06, 2023 | CHIEF FINANCIAL OFFICER | -5.18K | $4.83 | -$25.03K | SELL | -4.00% | 124.29K | Jul 05 | ||
Jun 15, 2023 | DIRECTOR | -3.46K | $5.58 | -$19.31K | SELL | -25.83% | 9.93K | Jun 14 | ||
Apr 21, 2023 | DIRECTOR | 276.64K | $6.17 | $1.71M | BUY | 2.15% | 13.14M | Apr 20 - Apr 21 | ||
Apr 19, 2023 | CHIEF MEDICAL OFFICER | -2.53K | $6.57 | -$16.65K | SELL | -1.77% | 140.68K | Apr 18 | ||
Apr 17, 2023 | DIRECTOR | -109.43K | $5.84 | -$1.61M | SELL | -0.84% | 12.86M | Apr 13 - Apr 14 | ||
Jan 13, 2023 | DIRECTOR | 124.68K | $5.60 | $698.14K | BUY | 78.87% | 282.77K | Jan 11 - Jan 13 | ||
Jan 11, 2023 | PRESIDENT AND CEO | -45.91K | $5.24 | -$240.55K | SELL | -10.64% | 385.64K | Jan 10 | ||
Jan 11, 2023 | CHIEF R&D OFFICER | -10.92K | $5.24 | -$57.21K | SELL | -6.07% | 168.92K | Jan 10 | ||
Jan 11, 2023 | GENERAL COUNSEL AND SECRETARY | -11.55K | $5.24 | -$60.54K | SELL | -6.11% | 177.60K | Jan 10 | ||
Jan 11, 2023 | CHIEF TECHNICAL OFFICER | -3.42K | $5.24 | -$17.91K | SELL | -2.69% | 123.70K | Jan 10 | ||
Jan 11, 2023 | CHIEF FINANCIAL OFFICER | -7.33K | $5.24 | -$38.41K | SELL | -5.36% | 129.47K | Jan 10 | ||
Jan 11, 2023 | CHIEF MEDICAL OFFICER | -7.83K | $5.24 | -$41.00K | SELL | -5.18% | 143.21K | Jan 10 | ||
Aug 19, 2022 | CHIEF FINANCIAL OFFICER | -5.13K | $29.81 | -$153.05K | SELL | -3.62% | 136.80K | Aug 18 | ||
Jul 25, 2022 | PRESIDENT AND CEO | 0.00 | $17.72 | -$1.09M | SELL-OPTIONS | 0.00% | 431.55K | Jul 21 - Jul 22 | ||
Jul 08, 2022 | CHIEF R&D OFFICER | 0.00 | $16.48 | -$471.85K | SELL-OPTIONS | 0.00% | 179.83K | Jul 07 | ||
Jul 07, 2022 | CHIEF R&D OFFICER | 0.00 | $16.67 | -$210.18K | SELL-OPTIONS | 0.00% | 179.83K | Jul 06 | ||
Jul 06, 2022 | CHIEF TECHNICAL OFFICER | -3.72K | $24.61 | -$91.52K | SELL | -2.84% | 127.12K | Jul 05 | ||
Jun 08, 2022 | DIRECTOR | -841.00 | $21.89 | -$18.41K | SELL | -31.37% | 1.84K | Jun 07 | ||
Jun 06, 2022 | DIRECTOR | -1.36K | $22.79 | -$31.09K | SELL | -0.86% | 158.09K | Jun 03 | ||
Jun 06, 2022 | DIRECTOR | -1.48K | $22.82 | -$33.84K | SELL | -55.32% | 1.20K | Jun 03 | ||
Jun 06, 2022 | DIRECTOR | -672.00 | $22.75 | -$15.29K | SELL | -25.07% | 2.01K | Jun 03 | ||
Jun 06, 2022 | DIRECTOR | -1.44K | $22.81 | -$32.82K | SELL | -2.44% | 57.63K | Jun 03 | ||
Jun 06, 2022 | DIRECTOR | -807.00 | $22.80 | -$18.40K | SELL | -30.10% | 1.87K | Jun 03 | ||
Jun 02, 2022 | GENERAL COUNSEL AND SECRETARY | 0.00 | $14.76 | -$410.25K | SELL-OPTIONS | 0.00% | 189.15K | Jun 01 | ||
Apr 25, 2022 | PRESIDENT AND CEO | 0.00 | $18.80 | -$1.29M | SELL-OPTIONS | 0.00% | 431.55K | Apr 21 - Apr 22 | ||
Apr 21, 2022 | CHIEF MEDICAL OFFICER | -4.06K | $35.37 | -$143.67K | SELL | -2.62% | 151.03K | Apr 19 | ||
Apr 04, 2022 | GENERAL COUNSEL AND SECRETARY | 0.00 | $22.04 | -$840.73K | SELL-OPTIONS | 0.00% | 189.15K | Apr 01 | ||
Mar 15, 2022 | CHIEF R&D OFFICER | 0.00 | $16.90 | -$708.48K | SELL-OPTIONS | 0.00% | 179.83K | Mar 14 | ||
Mar 11, 2022 | DIRECTOR | 0.00 | $18.32 | -$1.05M | SELL-OPTIONS | 0.00% | 159.46K | Mar 10 | ||
Jan 24, 2022 | PRESIDENT AND CEO | 0.00 | $21.19 | -$1.48M | SELL-OPTIONS | 0.00% | 431.55K | Jan 20 - Jan 21 | ||
Jan 13, 2022 | PRESIDENT AND CEO | -14.57K | $48.68 | -$709.03K | SELL | -3.27% | 431.55K | Jan 11 | ||
Jan 13, 2022 | GENERAL COUNSEL AND SECRETARY | -5.42K | $48.53 | -$262.97K | SELL | -3.36% | 155.85K | Jan 11 | ||
Jan 13, 2022 | CHIEF R&D OFFICER | -4.57K | $48.50 | -$221.66K | SELL | -3.02% | 146.53K | Jan 11 | ||
Jan 13, 2022 | CHIEF FINANCIAL OFFICER | -1.77K | $48.45 | -$85.76K | SELL | -1.60% | 108.63K | Jan 11 | ||
Jan 13, 2022 | SENIOR VP CLINICAL DEVELOPMENT | -3.96K | $48.51 | -$192.34K | SELL | -3.15% | 121.79K | Jan 11 | ||
Jan 12, 2022 | PRESIDENT AND CEO | -34.16K | $46.86 | -$1.60M | SELL | -7.11% | 446.11K | Jan 10 | ||
Jan 12, 2022 | GENERAL COUNSEL AND SECRETARY | -7.74K | $46.43 | -$359.31K | SELL | -4.58% | 161.27K | Jan 10 | ||
Jan 12, 2022 | CHIEF R&D OFFICER | -5.60K | $46.38 | -$259.56K | SELL | -3.57% | 151.10K | Jan 10 | ||
Jan 04, 2022 | GENERAL COUNSEL AND SECRETARY | 0.00 | $32.94 | -$2.64M | SELL-OPTIONS | 0.00% | 169.01K | Jan 03 | ||
Dec 21, 2021 | CHIEF FINANCIAL OFFICER | -1.54K | $47.76 | -$445.82K | SELL | -1.38% | 110.40K | Dec 20 | ||
Dec 14, 2021 | CHIEF R&D OFFICER | 0.00 | $25.19 | -$1.12M | SELL-OPTIONS | 0.00% | 156.70K | Dec 13 | ||
Dec 13, 2021 | SENIOR VP CLINICAL DEVELOPMENT | 0.00 | $33.89 | -$263.55K | SELL-OPTIONS | 0.00% | 125.76K | Dec 10 | ||
Nov 22, 2021 | PRESIDENT AND CEO | 86.47K | $28.49 | -$1.03M | SELL-OPTIONS | 21.96% | 480.27K | Nov 18 - Nov 19 | ||
Oct 25, 2021 | PRESIDENT AND CEO | 0.00 | $31.22 | -$3.40M | SELL-OPTIONS | 0.00% | 393.79K | Oct 21 - Oct 22 | ||
Oct 04, 2021 | GENERAL COUNSEL AND SECRETARY | 0.00 | $32.69 | -$2.61M | SELL-OPTIONS | 0.00% | 108.05K | Oct 01 | ||
Sep 30, 2021 | CHIEF FINANCIAL OFFICER | -2.13K | $49.03 | -$601.45K | SELL | -3.91% | 52.40K | Sep 28 | ||
Sep 14, 2021 | CHIEF DEVELOPMENT OFFICER | 0.00 | $34.51 | -$1.59M | SELL-OPTIONS | 0.00% | 95.74K | Sep 13 | ||
Aug 20, 2021 | PRESIDENT AND CEO | 0.00 | $46.42 | -$1.66M | SELL-OPTIONS | 0.00% | 393.79K | Aug 19 | ||
Aug 20, 2021 | CHIEF FINANCIAL OFFICER | -3.47K | $88.26 | -$306.60K | SELL | -5.99% | 54.54K | Aug 19 | ||
Jul 26, 2021 | PRESIDENT AND CEO | 0.00 | $44.55 | -$4.93M | SELL-OPTIONS | 0.00% | 393.79K | Jul 22 - Jul 23 | ||
Jul 02, 2021 | GENERAL COUNSEL AND SECRETARY | 0.00 | $45.44 | -$4.42M | SELL-OPTIONS | 0.00% | 108.05K | Jul 01 | ||
Jun 16, 2021 | CHIEF DEVELOPMENT OFFICER | 0.00 | $46.08 | -$2.16M | SELL-OPTIONS | 0.00% | 95.74K | Jun 14 | ||
May 24, 2021 | PRESIDENT AND CEO | 0.00 | $41.00 | -$1.45M | SELL-OPTIONS | 0.00% | 393.79K | May 20 | ||
Apr 26, 2021 | PRESIDENT AND CEO | 0.00 | $44.63 | -$4.89M | SELL-OPTIONS | 0.00% | 393.79K | Apr 22 - Apr 23 | ||
Apr 20, 2021 | SENIOR VP CLINICAL DEVELOPMENT | -3.27K | $83.30 | -$272.81K | SELL | -4.81% | 64.80K | Apr 16 | ||
Apr 02, 2021 | SEE REMARKS | 0.00 | $43.51 | -$2.42M | SELL-OPTIONS | 0.00% | 108.05K | Apr 01 | ||
Mar 16, 2021 | CHIEF DEVELOPMENT OFFICER | -50.00K | $47.63 | -$2.38M | SELL | -34.31% | 95.74K | Mar 15 | ||
Mar 09, 2021 | CHIEF SCIENTIFIC OFFICER | -25.00K | $81.74 | -$2.04M | SELL | -25.50% | 73.02K | Mar 08 | ||
Feb 19, 2021 | PRESIDENT AND CEO | 0.00 | $54.32 | -$1.91M | SELL-OPTIONS | 0.00% | 393.79K | Feb 18 | ||
Jan 22, 2021 | PRESIDENT AND CEO | 43.23K | $52.35 | -$5.80M | SELL-OPTIONS | 12.33% | 393.79K | Jan 20 - Jan 22 | ||
Jan 21, 2021 | GENERAL COUNSEL AND SECRETARY | 0.00 | $58.83 | -$3.92M | SELL-OPTIONS | 0.00% | 90.03K | Jan 19 | ||
Jan 12, 2021 | PRESIDENT AND CEO | -69.41K | $116.33 | -$8.07M | SELL | -16.53% | 350.56K | Jan 08 - Jan 11 | ||
Jan 12, 2021 | CHIEF DEVELOPMENT OFFICER | -9.48K | $114.95 | -$1.09M | SELL | -10.87% | 77.73K | Jan 08 - Jan 11 | ||
Jan 12, 2021 | GENERAL COUNSEL AND SECRETARY | -9.48K | $114.94 | -$1.09M | SELL | -9.53% | 90.03K | Jan 08 - Jan 11 | ||
Jan 12, 2021 | CHIEF SCIENTIFIC OFFICER | -9.48K | $114.95 | -$1.09M | SELL | -10.19% | 83.61K | Jan 08 - Jan 11 | ||
Jan 12, 2021 | DIRECTOR | 327.49K | $85.50 | $28.00M | BUY | 2.59% | 12.96M | Jan 08 | ||
Dec 18, 2020 | — | 0.00 | $49.22 | -$1.70M | OPTION EXERCISE | 0.00% | 419.97K | Dec 17 | ||
Dec 15, 2020 | — | 0.00 | $50.34 | -$2.37M | OPTION EXERCISE | 0.00% | 87.21K | Dec 14 | ||
Nov 16, 2020 | — | -25.00K | $51.83 | -$1.30M | SELL | -21.17% | 93.09K | Nov 16 | ||
Nov 16, 2020 | — | 0.00 | $28.05 | -$2.86M | OPTION EXERCISE | 0.00% | 419.97K | Nov 12 - Nov 13 | ||
Nov 06, 2020 | — | 0.00 | $26.61 | -$3.38M | OPTION EXERCISE | 0.00% | 99.52K | Nov 04 - Nov 05 | ||
Oct 20, 2020 | — | 0.00 | $26.49 | -$1.39M | OPTION EXERCISE | 0.00% | 99.52K | Oct 16 | ||
Oct 02, 2020 | — | 0.00 | $21.74 | -$1.33M | OPTION EXERCISE | 0.00% | 99.52K | Oct 01 | ||
Sep 16, 2020 | — | 0.00 | $19.52 | -$838.25K | OPTION EXERCISE | 0.00% | 87.21K | Sep 14 | ||
Sep 16, 2020 | — | -25.00K | $36.30 | -$907.54K | SELL | -17.47% | 118.09K | Sep 14 | ||
Jun 17, 2020 | — | 1.41M | $28.31 | $40.00M | PURCHASE | 12.60% | 12.63M | Jun 11 | ||
Feb 03, 2020 | — | 0.00 | $14.08 | -$568.80K | OPTION EXERCISE | 0.00% | 419.97K | Jan 30 | ||
Jan 10, 2020 | — | 19.30K | $20.69 | -$117.95K | GRANT OR AWARD | 28.91% | 86.06K | Jan 08 | ||
Jan 10, 2020 | — | 19.30K | $20.72 | -$118.09K | GRANT OR AWARD | 24.06% | 99.52K | Jan 08 | ||
Jan 10, 2020 | — | 19.30K | $20.70 | -$117.99K | GRANT OR AWARD | 15.59% | 143.09K | Jan 08 | ||
Jan 02, 2020 | — | 0.00 | $11.20 | -$414.93K | OPTION EXERCISE | 0.00% | 123.79K | Dec 30 | ||
Dec 23, 2019 | PRESIDENT AND CEO | 0.00 | $11.41 | -$871.05K | SELL-OPTIONS | 0.00% | 353.97K | Dec 19 - Dec 20 | ||
Oct 16, 2019 | PRESIDENT AND CEO | -21.02K | $14.44 | -$303.46K | SELL | -5.60% | 353.97K | Oct 15 | ||
Oct 16, 2019 | CHIEF DEVELOPMENT OFFICER | -6.20K | $14.18 | -$87.89K | SELL | -8.50% | 66.76K | Oct 15 | ||
Oct 16, 2019 | GENERAL COUNSEL AND SECRETARY | -10.20K | $14.24 | -$145.29K | SELL | -11.28% | 80.22K | Oct 15 | ||
Oct 16, 2019 | CHIEF SCIENTIFIC OFFICER | -11.80K | $14.29 | -$168.59K | SELL | -8.70% | 123.79K | Oct 15 | ||
Sep 17, 2019 | DIRECTOR | 857.14K | $17.50 | $15.00M | BUY | 8.27% | 11.22M | Sep 16 | ||
Aug 02, 2019 | DIRECTOR | -62.01K | $22.53 | -$1.40M | SELL | -84.89% | 11.03K | Jul 31 - Aug 01 | ||
Jul 30, 2019 | DIRECTOR | -118.33K | $22.51 | -$2.66M | SELL | -91.05% | 11.63K | Jul 26 - Jul 30 | ||
Jul 25, 2019 | DIRECTOR | -81.90K | $22.51 | -$1.84M | SELL | -86.50% | 12.78K | Jul 23 - Jul 24 | ||
Jul 22, 2019 | DIRECTOR | -71.17K | $22.52 | -$1.60M | SELL | -83.98% | 13.57K | Jul 18 - Jul 22 | ||
Jun 28, 2019 | CHIEF SCIENTIFIC OFFICER | 0.00 | $11.55 | -$216.36K | SELL-OPTIONS | 0.00% | 135.59K | Jun 27 | ||
May 17, 2019 | PRESIDENT AND CEO | 0.00 | $10.50 | -$254.32K | SELL-OPTIONS | 0.00% | 374.88K | May 16 | ||
Apr 19, 2019 | PRESIDENT AND CEO | 0.00 | $8.86 | -$289.04K | SELL-OPTIONS | 0.00% | 374.88K | Apr 17 - Apr 18 | ||
Mar 29, 2019 | CHIEF SCIENTIFIC OFFICER | 0.00 | $9.92 | -$175.45K | SELL-OPTIONS | 0.00% | 135.59K | Mar 28 | ||
Mar 22, 2019 | PRESIDENT AND CEO | 0.00 | $9.62 | -$319.56K | SELL-OPTIONS | 0.00% | 374.88K | Mar 21 | ||
Mar 05, 2019 | GENERAL COUNSEL AND SECRETARY | 0.00 | $9.52 | -$331.20K | SELL-OPTIONS | 0.00% | 90.42K | Mar 01 | ||
Feb 27, 2019 | GENERAL COUNSEL AND SECRETARY | 0.00 | $9.49 | -$329.32K | SELL-OPTIONS | 0.00% | 90.42K | Feb 25 | ||
Feb 01, 2019 | DIRECTOR | -53.02K | $14.16 | -$750.96K | SELL | -3.47% | 1.47M | Jan 30 | ||
Jan 31, 2019 | DIRECTOR | -97.50K | $14.16 | -$1.38M | SELL | -6.00% | 1.53M | Jan 29 | ||
Jan 30, 2019 | DIRECTOR | -70.00K | $13.78 | -$964.77K | SELL | -4.13% | 1.62M | Jan 28 | ||
Jan 29, 2019 | DIRECTOR | -90.00K | $14.14 | -$1.27M | SELL | -5.05% | 1.69M | Jan 25 | ||
Jan 23, 2019 | DIRECTOR | -39.48K | $16.28 | -$642.83K | SELL | -2.17% | 1.78M | Jan 18 | ||
Jan 09, 2019 | GENERAL COUNSEL AND SECRETARY | 45.00K | $9.13 | -$343.33K | SELL-OPTIONS | 99.08% | 90.42K | Jan 07 | ||
Dec 26, 2018 | DIRECTOR | -33.47K | $12.25 | -$410.16K | SELL | -1.80% | 1.82M | Dec 20 | ||
Dec 21, 2018 | DIRECTOR | -91.21K | $13.40 | -$1.22M | SELL | -4.68% | 1.86M | Dec 19 | ||
Dec 17, 2018 | DIRECTOR | -17.79K | $16.67 | -$296.56K | SELL | -0.90% | 1.95M | Dec 13 | ||
Dec 14, 2018 | DIRECTOR | -425.00K | $16.78 | -$7.13M | SELL | -17.78% | 1.97M | Dec 12 | ||
Dec 13, 2018 | DIRECTOR | -82.53K | $16.71 | -$1.38M | SELL | -3.34% | 2.39M | Dec 11 | ||
Sep 27, 2018 | DIRECTOR | 3.70M | $13.50 | $50.00M | BUY | 55.64% | 10.36M | Sep 25 | ||
Oct 17, 2017 | PRESIDENT AND CEO | -17.17K | $3.88 | -$66.60K | SELL | -12.09% | 124.88K | Oct 13 - Oct 16 | ||
Oct 17, 2017 | GENERAL COUNSEL AND SECRETARY | -8.09K | $3.85 | -$31.12K | SELL | -15.12% | 45.42K | Oct 13 - Oct 16 | ||
Oct 17, 2017 | CHIEF SCIENTIFIC OFFICER | -13.22K | $3.87 | -$51.20K | SELL | -12.74% | 90.59K | Oct 13 - Oct 16 | ||
Nov 28, 2016 | CHIEF MEDICAL OFFICER | 37.59K | $2.66 | $100.00K | BUY | 413.56% | 46.68K | Nov 23 | ||
Nov 28, 2016 | DIRECTOR | 375.94K | $2.66 | $1000.00K | BUY | 186.39% | 577.63K | Nov 23 | ||
Nov 28, 2016 | DIRECTOR | 56.39K | $2.66 | $150.00K | BUY | ∞ | 56.39K | Nov 23 | ||
Jun 12, 2014 | SEE REMARKS | 0.00 | $4.31 | -$34.95K | SELL-OPTIONS | 0.00% | 4.04K | Jun 11 - Jun 12 | ||
Jun 11, 2014 | SEE REMARKS | -1.35K | $4.31 | -$19.94K | SELL | -25.00% | 4.04K | Jun 09 - Jun 10 | ||
May 05, 2014 | SEE REMARKS | -1.35K | $4.34 | -$55.54K | SELL | -20.00% | 5.38K | May 01 | ||
Apr 07, 2014 | SEE REMARKS | 0.00 | $4.81 | -$37.51K | SELL-OPTIONS | 0.00% | 6.73K | Apr 04 | ||
Apr 03, 2014 | SEE REMARKS | 0.00 | $5.19 | -$76.48K | SELL-OPTIONS | 0.00% | 0.00 | Apr 01 - Apr 02 | ||
Apr 02, 2014 | CHIEF TECHNOLOGY OFFICER | -8.65K | $9.86 | -$85.36K | SELL | -25.00% | 25.96K | Mar 31 | ||
Apr 02, 2014 | SEE REMARKS | -4.04K | $9.79 | -$39.52K | SELL | -37.50% | 6.73K | Mar 31 - Apr 01 | ||
Apr 02, 2014 | SEE REMARKS | -20.00K | $9.64 | -$192.88K | SELL | -57.10% | 15.03K | Mar 31 - Apr 01 | ||
Oct 07, 2013 | 10% OWNER | 2.47M | $6.00 | $5.77M | BUY | ∞ | 2.47M | Oct 04 | ||
Oct 07, 2013 | 10% OWNER | 2.47M | $6.00 | $5.77M | BUY | ∞ | 2.47M | Oct 04 | ||
Oct 07, 2013 | DIRECTOR | 2.47M | $6.00 | $5.77M | BUY | ∞ | 2.47M | Oct 04 | ||
Oct 07, 2013 | 10% OWNER | 2.47M | $6.00 | $5.77M | BUY | ∞ | 2.47M | Oct 04 | ||
Oct 07, 2013 | DIRECTOR | 2.47M | $6.00 | $5.77M | BUY | ∞ | 2.47M | Oct 04 | ||
Oct 07, 2013 | DIRECTOR | 83.33K | $6.00 | $500.00K | BUY | 70.41% | 201.69K | Oct 04 | ||
Oct 07, 2013 | DIRECTOR | 16.67K | $6.00 | $100.00K | BUY | 11.90% | 156.77K | Oct 04 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.